# Sponsor Brief - processor Business

## Sponsor Information

- **Business**: processor (Brief 2: Processor (Pharma-Grade Papain Refining, Barbados))
- **Brief Source**: brief-2-processor.md
- **Sponsor Commitment**: Business model design for processor venture
- **Decision Authority**: Primary sponsor for venture development

## Business Context

**Value Proposition**: Produce ≥6,000 USP U/mg papain powder, sterile and GMP-certified.. Offer Caribbean-based, Western-regulated quality alternative to Asian suppliers.. Enable pharma & cosmetic buyers to source closer to Western markets.

**Target Market**: Pharmaceutical ingredient distributors (Merck, Mitsubishi, Sigma).. Wound care, nutraceutical, cosmetics companies.

## Initial Scope

- **Core Activities**: Purification: ultrafiltration, chromatography, lyophilisation.. Quality & regulatory compliance (GMP, HACCP, CoA).. Packaging and sterile handling.
- **Key Resources**: 25+ ha high-latex orchards (or secure crude supply).. GMP-compliant facility (≈BDS $1.5–2M CAPEX).. Skilled technicians & QA lab.
- **Revenue Model**: Pharma-grade papain (US $60–90/kg).. Custom grades (sterile, high-activity).
- **Capital Requirements**: $250000 - $1000000 BBD
- **Timeline**: 3-year financial horizon

## Critical Constraints

- **Market Risks**: Scale mismatch (10 ha too small; ≥16 ha baseline).. High fixed costs vs fluctuating demand.. Regulatory hurdles (FDA, EMA).
- **Financial**: Discount rate 15%, capital bounds $250000-$1000000 BBD

## Success Criteria

- [ ] Viable business model within capital bounds
- [ ] Competitive market positioning established
- [ ] Risk mitigation strategies defined
- [ ] Sustainable revenue streams validated

## Next Steps

- [ ] Confirm sponsor commitment to venture
- [ ] Validate decision authority for investment
- [ ] Document regulatory and operational constraints
